LAMA, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 457
EU - Europa 421
AS - Asia 398
AF - Africa 29
SA - Sud America 24
Totale 1.329
Nazione #
US - Stati Uniti d'America 453
CN - Cina 128
GB - Regno Unito 112
SG - Singapore 108
IT - Italia 66
SE - Svezia 66
VN - Vietnam 65
DE - Germania 41
HK - Hong Kong 33
FR - Francia 23
IE - Irlanda 21
CH - Svizzera 17
IN - India 17
BR - Brasile 16
RU - Federazione Russa 16
UA - Ucraina 14
GR - Grecia 11
NL - Olanda 10
JP - Giappone 9
KR - Corea 9
JO - Giordania 8
TG - Togo 8
EE - Estonia 7
CI - Costa d'Avorio 6
NG - Nigeria 6
ZA - Sudafrica 6
AR - Argentina 4
FI - Finlandia 4
BG - Bulgaria 3
CA - Canada 3
PL - Polonia 3
SA - Arabia Saudita 3
TH - Thailandia 3
TR - Turchia 3
ID - Indonesia 2
OM - Oman 2
PH - Filippine 2
SC - Seychelles 2
UZ - Uzbekistan 2
VE - Venezuela 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BE - Belgio 1
CY - Cipro 1
EC - Ecuador 1
ES - Italia 1
GY - Guiana 1
IR - Iran 1
KY - Cayman, isole 1
LT - Lituania 1
MA - Marocco 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 1.329
Città #
Southend 103
Singapore 73
Fairfield 48
Chandler 46
Ashburn 45
Hong Kong 33
Hefei 24
Houston 24
Santa Clara 24
Beijing 23
Dublin 21
Hanoi 19
Princeton 19
Ann Arbor 18
San Jose 18
Ho Chi Minh City 17
Wilmington 17
Bern 16
Seattle 16
Woodbridge 14
Cambridge 13
Boardman 9
Nanchang 9
Westminster 9
Amman 8
Bologna 8
Lomé 8
Medford 8
Nanjing 8
Padova 8
Seoul 8
Abidjan 6
Jacksonville 6
Lauterbourg 6
New York 6
Tokyo 6
Buffalo 5
Los Angeles 5
Shenyang 5
São Paulo 5
Turin 5
Bremen 4
Florence 4
Rome 4
San Diego 4
Ancona 3
Berlin 3
Changsha 3
Da Nang 3
Grafing 3
Helsinki 3
Lanzhou 3
Munich 3
Shanghai 3
Sofia 3
Abeokuta 2
Alfonsine 2
Athens 2
Bengaluru 2
Bühl 2
Dallas 2
Dearborn 2
Dongguan 2
Haiphong 2
Istanbul 2
Jianning 2
Jinan 2
Lanús 2
Medina 2
Milan 2
Montepulciano 2
Muscat 2
Orem 2
Phuket 2
Piana degli Albanesi 2
Redwood City 2
Riolo Terme 2
San Mateo 2
Taizhou 2
Tashkent 2
Tianjin 2
Vicenza 2
Warsaw 2
Washington 2
Yubileyny 2
Amsterdam 1
Ancol 1
Andover 1
Andradina 1
Ankara 1
Araraquara 1
Atlanta 1
Augusta 1
Bagé 1
Bakhchysarai 1
Bang Lamung 1
Barnet 1
Belgrade 1
Bolzano 1
Boston 1
Totale 890
Nome #
Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience 351
Fludarabine, Cytarabine, Idarubicin and Etoposide (FLAIE) schedule is safe and active for young patients with newly diagnosed acute myeloid leukemia (AML): Results of a multicentric phase III Italian study 181
Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients 163
Innovative phase I-II study of concomitant and consecutive treatment with Dasatinib and MK-0457 in refractory Ph+ CML and ALL patients 149
PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients 143
A phase I study of Tipifarnib and Bortezomib in the treatment of poor risk adult acute myeloid leukemia (AML) 126
RASGRP1/APTX ratio is a strong biomarker which predicts response to therapy with Tipifarnib plus Bortezomib in elderly patients with Acute Myeloid Leukemia (AML) 125
PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients 125
Totale 1.363
Categoria #
all - tutte 3.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.466


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 10 4 10
2021/2022162 7 5 10 15 18 14 0 9 12 13 22 37
2022/2023205 19 32 6 26 12 16 8 15 41 3 11 16
2023/202457 1 13 3 4 3 11 8 2 5 2 2 3
2024/2025160 10 13 13 10 36 8 8 5 0 10 8 39
2025/2026365 39 36 39 17 41 16 23 10 114 30 0 0
Totale 1.363